An interim look at an ongoing study of 10,000 patients with no history of liver disease was conducted in community-based endoscopy centers by the Florida Research Institute (FRI), a global leader in disease research, and funded by Echosens, the makers of FibroScan, will be presented at the American College of Gastroenterology (ACG) Annual Meeting, in Philadelphia, PA on October 9th, 2018.
October 9, 2018
· 3 min read